跳至主要内容
临床试验/DRKS00009495
DRKS00009495已完成不适用

Multicenter study on the role of fructose malabsorption in ulcerative colitis and Crohn’s disease - Fructo-IBD

CED Service GmbH0 个研究点目标入组 251 人开始时间: 2015年10月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
251

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • Inclusion criteria for active IBD patients:
  • 1. Colitis ulcerosa or Crohn’s disease of the colon
  • 2. Crohn’s disease: Harvey-Bradshaw Index = 7
  • 3. Colitis ulcerosa: Powell-Tuck Index > 4
  • 4. No small bowel and colon resection
  • 5. Age between 18- 80 years
  • Inclusion criteria for IBD patients in remission:
  • 1. Colitis ulcerosa or Crohn’s disease of the colon
  • 2. Crohn’s disease: Harvey-Bradshaw Index < 4
  • 3. Colitis ulcerosa: Powell-Tuck Index = 4
  • 4. No small bowel and colon resection
  • 5. Age between 18- 80 years
  • Inclusion criteria for control group patients:
  • 1. No known abdominal symptoms
  • 2. No postprandial symptoms
  • 3. Age between 18- 80 years

排除标准

  • 1. Antibiotics therapy up to 4 weeks before the examination
  • 2. Inability to full fill the criteria of the study protocol
  • 3. Condition after a small bowel and colon resection
  • 4. Operation within last 3 months (gastro-intestinal tract)
  • 5. Unstable thyroid diseases (no constant medication within last year)
  • 6. Known Diabetes mellitus
  • 7. Chronic liver diseases (transaminases > twice of normal value); last blood test results should be not older than 6 weeks
  • 8. Renal dysfunction (serumkreatinin > 1,2 mg/dl); last blood test results should be not older than 6 weeks
  • 9. Intake of medication, which influence absorption, metabolism and excretion of food components or gastro-intestinal motility (e.g. metoclopramide, diuretics, laxatives etc.)
  • 10. Legal incapacity or limited legal incapacity
  • 11. Other exclusion criteria at the investigator’s discretion

研究者

相似试验

已完成
不适用
Prevalence of fructose malabsorption in patients with gout.GoutIntestinal fructose malabsorptionThe proposed investigation aims to identify the rates of fructose malabsorption in patients with gout. It is anticipated that this will then lead to further studies of dietary manipulation in patients with and without fructose malabsorption to determine whether dietary fructose restriction results in reduction in serum urate to a greater or lesser extent in each group.Intestinal fructose malabsorptionThe proposed investigation aims to identify the rates of fructose malabsorption in patients with gout. It is anticipated that this will then lead to further studies of dietary manipulation in patients with and without fructose malabsorption to determine whether dietary fructose restriction results in reduction in serum urate to a greater or lesser extent in each group.Musculoskeletal - Other muscular and skeletal disordersOral and Gastrointestinal - Normal oral and gastrointestinal development and function
ACTRN12612000879864niversity of Otago, Christchurch200
已完成
Unknown
Fructo-oligosaccharide intake and salivary IgA secretiooral disease
JPRN-UMIN000049275Kanagawa Dental University30
已完成
不适用
Research on the effect of fructose, sucrose and isomaltulose on uric acid metabolism.Healthy adult
JPRN-UMIN000047117The University of Shizuoka10
已完成
2 期
Fructose Malabsorption in Northern NorwayFructose MalabsorptionIrritable Bowel Syndrome
NCT00555191University Hospital of North Norway182
已完成
2 期
The effect of probiotic and antibiotic drugs on diarrheainfectious diarrhea.Other and unspecified gastroenteritis and colitis of infectious origin
IRCT20170316033099N8Zabol University of Medical Sciences120